Neumora Therapeutics, INC. (NMRA) SEC Filings — 2025

Filings

• Neumora Therapeutics, INC. 8-K Filing — 8-K · Nov 21, 2025
• Neumora Narrows Losses Amid R&D Cuts, Cash Reserves Dwindle — 10-Q · Nov 6, 2025
• Neumora Therapeutics Files 8-K — 8-K · Oct 27, 2025
• Neumora's Q2 Loss Widens Amid R&D Surge — 10-Q · Aug 6, 2025
• Neumora Therapeutics Files 8-K on Security Holder Vote — 8-K · May 30, 2025
• Neumora Therapeutics Faces Delisting Concerns — 8-K · May 16, 2025
• Neumora Therapeutics Files Q1 2025 10-Q — 10-Q · May 12, 2025
• Neumora Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 29, 2025
• Neumora Therapeutics Files 8-K/A Amendment — 8-K/A · Apr 11, 2025
• Neumora Therapeutics, INC. 10-K Filing — 10-K · Mar 3, 2025
• Neumora Therapeutics Files 8-K/A Amendment — 8-K/A · Feb 21, 2025
• Neumora Therapeutics Files 8-K on Executive Changes — 8-K · Feb 13, 2025
• Neumora Therapeutics Files 8-K — 8-K · Jan 13, 2025
• Neumora Therapeutics Files 8-K — 8-K · Jan 2, 2025